Linalool is a floral terpene alcohol best known from lavender, and it also appears in coriander and many cannabis varieties. Menus label it “calming” or “relaxing.” Research in animals gives that idea some support, with an interesting twist: the effect may come through the nose.

In a 2018 mouse study, simply smelling linalool reduced anxiety-like behavior without impairing movement. The effect disappeared in mice that couldn’t smell and was blocked by a drug that blocks benzodiazepine sites on GABA-A receptors. A 2021 mouse study found linalool produced some cannabinoid-like behaviors, while a 2019 cell study found it did not activate CB1 or CB2. We found no controlled human trial testing linalool as part of cannabis.
The Smell Study
Researchers at Kagoshima University in Japan exposed mice to linalool vapor and ran standard anxiety tests. The mice behaved less anxiously and showed no motor impairment. The key experiment used mice whose sense of smell had been eliminated: in them, linalool had no effect. The calming effect was also blocked by flumazenil, a drug that blocks the benzodiazepine sites on GABA-A receptors. The authors concluded that the effect was triggered by smell and involved GABA signaling. The study was published in 2018 in Frontiers in Behavioral Neuroscience.
For cannabis, this raises a possibility rather than proving anything. If some terpene effects work through smell, aroma itself could shape a person’s experience, along with their expectations about that aroma.
Linalool and the Cannabinoid Receptors
| Study | Method | Finding for linalool |
|---|---|---|
| Santiago et al., 2019 | Human CB1 and CB2 receptors in cells | No activation; no change to THC’s signaling |
| LaVigne et al., 2021 | Mouse behavior tests and cell assays | Produced some cannabinoid-like behaviors and activated CB1 in cells |
The two studies used different methods and reached different conclusions, which is typical of terpene research right now. Neither tells us what the small amount of linalool in cannabis does in a person.
What Reviews Say
A 2024 systematic review in Pharmaceuticals listed linalool among terpenes with exploratory evidence as a sleep aid and for mental stress, but concluded that terpenes boosting cannabinoids remains unproven. A 2026 Johns Hopkins review noted that many terpenes, linalool among them, have barely begun to be studied in humans together with THC.
What This Means for You
- If you enjoy a floral, lavender-like aroma, linalool is the terpene to look for on a lab report.
- Don’t treat a linalool label as an anxiety treatment. The supporting evidence is from mice.
- For anxiety, the best-supported cannabis advice is about THC dose. See our cannabis and anxiety research review, and talk with a clinician about ongoing anxiety.
Clear answers
Frequently Asked Questions
Is Linalool Calming?
In mice, smelling linalool reduced anxiety-like behavior without motor impairment. We found no controlled human trial testing linalool in cannabis for calm or anxiety.
Where Else Is Linalool Found?
Linalool is best known from lavender and is also found in coriander and many other aromatic plants.
Does Linalool Act on Cannabinoid Receptors?
Studies disagree. A 2019 cell study found no CB1 or CB2 activation, while a 2021 study reported CB1 activation and cannabinoid-like behaviors in mice.
Why Did Linalool Have No Effect on Some Mice?
In the 2018 study, mice without a sense of smell showed no calming effect, which suggests the effect was triggered through the olfactory system.
Sources
- Harada H et al., “Linalool Odor-Induced Anxiolytic Effects in Mice,” Frontiers in Behavioral Neuroscience, 2018
- Santiago M et al., “Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors,” Cannabis and Cannabinoid Research, 2019
- LaVigne JE et al., “Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity,” Scientific Reports, 2021
- André R et al., “The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review,” Pharmaceuticals, 2024
- Elder HJ et al., “A Critical Review of the Interactions Between Δ9-THC and Other Naturally Occurring Phytochemical Constituents of Cannabis sativa,” Current Neuropharmacology, 2026 (online ahead of print)